INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 – MDXG

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / The following statement is being issued by Levi
& Korsinsky, LLP:

To: All persons or
entities who purchased or otherwise acquired securities of MiMedx Group Inc.
(“MiMedx”) (NASDAQ: MDXG) between March 7,
2013 and February 21, 2018. You
are hereby notified that a securities class action lawsuit
has been commenced in the USDC for the Southern District of New York. To get
more information, go to:

http://www.zlk.com/pslra-d/mimedx-group-inc?wire=1

or contact Joseph E. Levi, Esq. either
via email at jlevi@levikorsinsky.com or by telephone
at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or
obligation to you.

The complaint alleges that, throughout
the Class Period, Defendants issued materially false and/or misleading
statements and/or failed to disclose that: (i) MiMedx was engaged in a “channel-stuffing”
scheme designed to inappropriately recognize revenue that had not yet been
realized; (ii) the Company lacked adequate internal controls over financial
reporting; and (iii) that as a result of the foregoing, MiMedx’s publicly
disseminated financial statements were materially false and
misleading.

On February 20, 2018, MiMedx announced
that it would postpone the release of its financial results and Form 10-K
filing for 2017. MiMedx stated it had engaged “independent legal and
accounting advisors to conduct an internal investigation into current and
prior-period matters relating to the allegations regarding certain sales and
distribution practices at the Company.” Following this
news, shares of MiMedx fell from a close of $14.47 per share on February 16,
2018 to a close of $8.75 on February 20, 2018.

If you suffered a loss in
MiMedx, you have until April 25, 2018 to
request that the Court appoint you as lead plaintiff. Your ability to share in
any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national
firm with offices in New York, California, Connecticut, and Washington D.C. The
firm’s attorneys have extensive expertise and experience representing investors
in securities litigation, and have recovered hundreds of millions of dollars
for aggrieved shareholders. Attorney advertising. Prior results do not
guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE:
Levi & Korsinsky, LLP

ReleaseID: 495569